KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $19,000 | +35.7% | 5,600 | +41.7% | 0.00% | – |
Q2 2018 | $14,000 | -65.9% | 3,953 | -44.0% | 0.00% | -100.0% |
Q4 2016 | $41,000 | -73.2% | 7,057 | -75.6% | 0.00% | -80.0% |
Q3 2016 | $153,000 | +12.5% | 28,898 | +40.6% | 0.01% | +11.1% |
Q2 2016 | $136,000 | +248.7% | 20,554 | +144.7% | 0.01% | +200.0% |
Q1 2016 | $39,000 | +18.2% | 8,398 | +27.3% | 0.00% | 0.0% |
Q4 2015 | $33,000 | +83.3% | 6,598 | +249.5% | 0.00% | +50.0% |
Q2 2015 | $18,000 | +157.1% | 1,888 | +213.1% | 0.00% | +100.0% |
Q1 2015 | $7,000 | – | 603 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |